ATS 2020 Advance Program

Chairing: N.A. Shah, MD, MPH, MSci, New York, NY N.H. Stewart, DO, Omaha, NE 11:45 Introduction N.A. Shah, MD, MPH, MSci, New York, NY 11:50 Responsible Social Media Use N. Seam, MD, ATSF, Bethesda, MD 12:00 Why Use Digital Scholarship to Create Research Impact? A.E. Turnbull, DVM, MPH, PhD, Baltimore, MD 12:15 #AcademicTwitter Management M.A. Pisani, MD, MPH, New Haven, CT 12:30 Digital Scholarship for Academic Promotion A. Malhotra, MD, ATSF, La Jolla, CA 12:45 Facilitated Twitter Setup N.H. Stewart, DO, Omaha, NE 12:55 Creating a Visual Research Abstract E. Carlton, MD, Ann Arbor, MI 1:10 Summary and Discussion N.A. Shah, MD, MPH, MSci, New York, NY CLINICAL WORKSHOP WS4 CLOSING THE QUALITY GAP IN MALIGNANT PLEURAL EFFUSION Registration Fee: $75 (includes box lunch) Attendance is limited. Pre-registration is required. Assembly on Clinical Problems 11:45 a.m. - 1:15 p.m. Target Audience Thoracic clinicians involved in the diagnosis and management of malignant pleural effusions. Objectives At the conclusion of this session, the participant will be able to: • select among available interventions for symptomatic malignant pleural effusion depending on patient characteristics; • account for prognosis in choosing the optimal intervention for a given patient with malignant pleural effusion; • appreciate the most glaring quality gaps in malignant pleural effusion management. Malignant pleural effusion (MPE) is a challenging clinical entity in respiratory medicine. Its discovery signifies advanced malignancy, therefore demanding that clinicians streamline therapeutics to minimize discomfort, inpatient stay, and impact on quality of life. The approach to MPE management is known to vary greatly and to commonly deviate from recommended best practice. During this workshop, attendees will hear presentations by some of the world’s thought leaders in pleural disease on ways to optimize the therapeutic approach to MPE. Attendees will participate by answering case-based questions posed by the presenters using an audience response system. There will be an opportunity for Q&A with the expert panel. Chairing: O. Epelbaum, MD, ATSF, Valhalla, NY H. Grosu, DrMed, Houston, TX 11:45 Introduction O. Epelbaum, MD, ATSF, Valhalla, NY 11:50 Is There a Role for Thoracentesis in MPE Management? J. Akulian, MD, MPH, ATSF, Chapel Hill, NC 12:05 Pleurodesis or IPC: Still the Binary Choice for Definitive Management H. Grosu, DrMed, Houston, TX 12:20 Is a Combined Approach the Holy Grail? N. Rahman, BMBCH, MSc, Oxford, UnitedKingdom 12:35 Quality Gaps in MPE Management: Take-Home Messages D.E. Ost, MD, MPH, Houston, TX 12:50 Wrap-Up: Questions and Answers ATS 2020 • Philadelphia, PA MONDAY • MAY 18 77